The Valens Company Increases Domestic Reach with Distribution Agreement with Yukon Territory

Valens can now ship products to five provinces and one territory in Canada

KELOWNA, BC, April 21, 2021 /PRNewswire/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a leading manufacturer of cannabis products, today announced its entry into the Yukon market with a cannabis purchase and sale agreement with the Yukon Liquor Corporation (YLC).

The agreement allows for the sale and distribution of Valens-manufactured products to licensed cannabis retailers in Yukon and on Cannabis Yukon, Yukon Liquor Corporation’s ecommerce platform. Valens expects to bring a range of Cannabis 2.0 and 3.0 products to the Yukon market, which could include vapes, concentrates, beverages, topicals and edibles, expanding the variety of innovative formats available in the territory.

Our entry into the Yukon market not only furthers our ability to capture market share in Canada, but also broadens the selection and quality of products that consumers in the territory can access.

Tyler Robson, CEO, Co-Founder and Chair of The Valens Company

We have made significant progress growing our cannabis distribution network and we expect to increase our national position in the short-term as we continue discussions with other private and government-regulated retailers across the country.

Valens-manufactured products will be shipped to Yukon and available to consumers in the coming quarters.

At Valens, it’s Personal.

About The Valens Company

The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company provides proprietary cannabis processing services across five core technologies, in addition to best-in-class product development, formulation and manufacturing of cannabis consumer packaged goods. The Valens Company’s high-quality products are exclusively formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on next-generation product development and innovation. Its breakthrough patented emulsification technology, SōRSE™ by Valens, converts cannabis oil into water-soluble emulsions for seamless integration into a variety of product formats, allowing for near-perfect dosing, stability, and taste. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, the Company continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences in key markets. Through its wholly owned subsidiary Valens Labs Ltd., the Company is setting the standard in cannabis testing and research and development with Canada’s only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific. Discover more on The Valens Company and its subsidiaries at http://www.thevalenscompany.com.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter